ESR1 and breast cancer: It is well documented that in MCF-7 breast cancer cells ER-α mRNA can undergo alternative splicing, generating transcripts with single, double, or multiple exon deletions [42], and that a 52 kDa protein is translated from the predominant splice variant mRNA that is missing exon 7 [43].